← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Connecticut Children'S Medical Center
Hartford, CT
$31,964,108
Total funding
23
Grants
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,037,776 · 20
DOD$662,430 · 1
CDC$263,902 · 2
By mechanism
U01$19,098,899 · 4
R33$3,196,161 · 1
K23$2,017,079 · 5
K08$1,891,733 · 3
R61$1,880,263 · 1
U34$1,278,461 · 3
Investigators at Connecticut Children'S Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease$2,900,000
U01 · FY2025 · DK
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease$2,799,999
U01 · FY2023 · DK
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease$2,701,767
U01 · FY2024 · DK
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study$2,684,971
U01 · FY2012 · DK
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study$2,522,332
U01 · FY2013 · DK
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study$2,311,223
U01 · FY2014 · DK
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)$1,637,600
R33 · FY2023 · HD
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study$1,581,943
U01 · FY2015 · DK
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)$1,558,561
R33 · FY2023 · HD
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study$1,332,762
U01 · FY2016 · DK
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)$877,921
R61 · FY2021 · HD
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)$807,142
R61 · FY2022 · HD
IDENTIFICATION OF NEW DIAGNOSTIC BIOMARKERS FOR INTRACRANIAL GERM CELL TUMORS$662,430
· FY2022 · Defense Health Agency
Predicting Response to Standardized Pediatric Colitis Therapy: The PROTECT Study$424,535
U34 · FY2010 · DK
Clinical, imaging, and endoscopic outcomes of children newly diagnosed with Crohn's disease$391,223
U34 · FY2021 · DK
The Asthma Neighborhood: Collaborative for Asthma Equity (CASE) in Children$381,060
U34 · FY2015 · HL
HEALTH BURDERN OF COINFECTING DEER ASSOCIATED ZOONOSES$359,913
R01 · FY2001 · AI
HEALTH BURDERN OF COINFECTING DEER ASSOCIATED ZOONOSES$350,069
R01 · FY2000 · AI
Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention$273,211
K08 · FY2025 · CA
Improving Sexual and Reproductive Health Communication Between Adolescent and Young Adult Oncology Patients and Clinicians: A Patient-Centered Intervention$273,211
K08 · FY2024 · CA